Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea

Clozapine is approved by the US Food and Drug Administration for treatment-resistant schizophrenia and mitigation of suicidality in patients with schizophrenia or schizoaffective disorder. Clozapine requires monitoring of adverse events, such as hypotension, myocarditis, cardiomyopathy, seizures, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Jonathan G., Kutzke, Jade L., Morgan, Robert J., Schak, Kathryn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956972/
https://www.ncbi.nlm.nih.gov/pubmed/31942277
http://dx.doi.org/10.9740/mhc.2020.01.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956972/
https://www.ncbi.nlm.nih.gov/pubmed/31942277
http://dx.doi.org/10.9740/mhc.2020.01.034

Ejemplares similares